Blueprint Medicines Stock Quote 0HOJ - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

82.54

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

82.54 52 Week Range 82.54

Market Cap

5.018B

Previous Close

82.54

Open

Last Trade

89.16

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

381

Shares Outstanding

60,790,000

Dividend Yield

PE Ratio

-10.73

Earnings Per Share (EPS)

-8.34

Revenue

249.38M

Net Profit

-506.98M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.blueprintmedicines.com

Headquarters

Wilmington, Delaware, USA

Founded

Blueprint Medicines Corp is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0HOJ. The last closing price for Blueprint Medicines was $82.54. Over the last year, Blueprint Medicines shares have traded in a share price range of $ 82.54 to $ 82.54.

Blueprint Medicines currently has 60,790,000 shares outstanding. The market capitalization of Blueprint Medicines is $5.02 billion. Blueprint Medicines has a price to earnings ratio (PE ratio) of -10.73.

No news to show yet.

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	82.54	82.54	82.54	163	82.54	DE
4	82.54	82.54	82.54	163	82.54	DE
12	82.54	82.54	82.54	381	82.54	DE
26	82.54	82.54	82.54	242	82.54	DE
52	82.54	82.54	82.54	223	82.54	DE
156	82.54	82.54	82.54	100	82.54	DE
260	82.54	82.54	82.54	96	82.54	DE

0HOJ - Frequently Asked Questions (FAQ)

What is the current Blueprint Medicines share price?

The current share price of Blueprint Medicines is $ 82.54

How many Blueprint Medicines shares are in issue?

Blueprint Medicines has 60,790,000 shares in issue

What is the market cap of Blueprint Medicines?

The market capitalisation of Blueprint Medicines is USD 5.02B

What is the 1 year trading range for Blueprint Medicines share price?

Blueprint Medicines has traded in the range of $ 82.54 to $ 82.54 during the past year

What is the PE ratio of Blueprint Medicines?

The price to earnings ratio of Blueprint Medicines is -10.73

What is the cash to sales ratio of Blueprint Medicines?

The cash to sales ratio of Blueprint Medicines is 21.81

What is the reporting currency for Blueprint Medicines?

Blueprint Medicines reports financial results in USD

What is the latest annual turnover for Blueprint Medicines?

The latest annual turnover of Blueprint Medicines is USD 249.38M

What is the latest annual profit for Blueprint Medicines?

The latest annual profit of Blueprint Medicines is USD -506.98M

What is the registered address of Blueprint Medicines?

The registered address for Blueprint Medicines is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Blueprint Medicines website address?

The website address for Blueprint Medicines is www.blueprintmedicines.com

Which industry sector does Blueprint Medicines operate in?

Blueprint Medicines operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SCGLSealand Capital Galaxy Limited	3.25p (103.13%)	12.18M
BORBorders & Southern Petroleum Plc	3.64p (51.04%)	23.81M
NEONeo Energy Metals Plc	0.95p (22.58%)	37.84M
GNIPGenip Plc	32.00p (20.75%)	192.82k
ZIOCZanaga Iron Ore Company Limited	10.50p (19.86%)	2.84M
DGIDg Innovate Plc	0.02p (-20.00%)	298.54M
SNGSynairgen Plc	2.10p (-19.39%)	1.67M
VRSVersarien Plc	0.03p (-18.92%)	103.72M
QEDQuadrise Plc	5.90p (-17.83%)	17.66M
ZENZenith Energy Ltd.	4.90p (-16.24%)	1.48M
SYMESupply@me Capital Plc	0.0042p (12.00%)	1.19B
MSMNMosman Oil And Gas Limited	0.035p (12.90%)	654.48M
TRPTower Resources Plc	0.0395p (0.00%)	570.56M
CPXCap-xx Limited	0.1775p (-2.74%)	379.2M
NTVONativo Resources Plc	0.0019p (-5.00%)	312.89M